The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

Abstract Background There is growing interest in identifying sensitive composite cognitive tests to serve as primary endpoints in preclinical Alzheimer’s disease (AD) treatment trials. We reported previously a composite cognitive test score sensitive to tracking preclinical AD decline up to 5 years...

Full description

Bibliographic Details
Main Authors: Jessica B. Langbaum, Noel N. Ellison, Angelika Caputo, Ronald G. Thomas, Carolyn Langlois, Marie-Emmanuelle Riviere, Ana Graf, Cristina Lopez Lopez, Eric M. Reiman, Pierre N. Tariot, Suzanne B. Hendrix
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Preclinical Alzheimer’s disease
Cognition
Composite cognitive endpoint
Clinical trials
Online Access:http://link.springer.com/article/10.1186/s13195-020-00633-2

Internet

http://link.springer.com/article/10.1186/s13195-020-00633-2

Similar Items